Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Jake Liang

Showing results (121-130 of 220) with videos related to

Pageof 22
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 4, 2006
Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvementGlen Lutchman, Kittichai Promrat, David E Kleiner, et al.
Hepatology (Baltimore, Md.)|August 21, 2008
Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutationTakanobu Kato, Youkyung Choi, Gamal Elmowalid, et al.
Hepatology (Baltimore, Md.)|October 24, 2002
Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis CAlejandro Soza, James E Everhart, Marc G Ghany, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2012
Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis BN Gara, X Zhao, M T Collins, et al.
The Journal of Clinical Investigation|October 9, 2014
Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine modelArnaud Carpentier, Abeba Tesfaye, Virginia Chu, et al.
Molecular Therapy. Nucleic Acids|May 26, 2022
A dual conditional CRISPR-Cas9 system to activate gene editing and reduce off-target effects in human stem cellsSeung Bum Park, Takuro Uchida, Samantha Tilson, et al.
Hepatology (Baltimore, Md.)|March 25, 2006
Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infectionPonni Perumalswami, David E Kleiner, Glen Lutchman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 13, 2014
Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adultsNaveen Gara, Adil Abdalla, Elenita Rivera, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patientsBirgit Edlich, Golo Ahlenstiel, Aintzane Zabaleta Azpiroz, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infectionNabora Soledad Reyes de Mochel, Scott Seronello, Shelley Hsiuying Wang, et al.
Pageof 22

Showing results (121-130 of 220) with videos related to

Sort By:
Pageof 22
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 4, 2006
Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvementGlen Lutchman, Kittichai Promrat, David E Kleiner, et al.
Hepatology (Baltimore, Md.)|August 21, 2008
Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutationTakanobu Kato, Youkyung Choi, Gamal Elmowalid, et al.
Hepatology (Baltimore, Md.)|October 24, 2002
Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis CAlejandro Soza, James E Everhart, Marc G Ghany, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2012
Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis BN Gara, X Zhao, M T Collins, et al.
The Journal of Clinical Investigation|October 9, 2014
Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine modelArnaud Carpentier, Abeba Tesfaye, Virginia Chu, et al.
Molecular Therapy. Nucleic Acids|May 26, 2022
A dual conditional CRISPR-Cas9 system to activate gene editing and reduce off-target effects in human stem cellsSeung Bum Park, Takuro Uchida, Samantha Tilson, et al.
Hepatology (Baltimore, Md.)|March 25, 2006
Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infectionPonni Perumalswami, David E Kleiner, Glen Lutchman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 13, 2014
Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adultsNaveen Gara, Adil Abdalla, Elenita Rivera, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patientsBirgit Edlich, Golo Ahlenstiel, Aintzane Zabaleta Azpiroz, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infectionNabora Soledad Reyes de Mochel, Scott Seronello, Shelley Hsiuying Wang, et al.
Pageof 22